Advertisement

Topics

Cellceutix Settles with Former CEO for $1M

11:56 EST 15 Feb 2011 |

Cellceutix, a Beverly, MA-based developer of drugs for cancer and other diseases, says that the company and its former CEO George Evans have settled a compensation dispute. The company has agreed to buy 4.6 million shares of stock held by Evans, a former Pfizer lawyer, and/or his sons over the past three years for $1 [...]

Original Article: Cellceutix Settles with Former CEO for $1M

NEXT ARTICLE

More From BioPortfolio on "Cellceutix Settles with Former CEO for $1M"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...